Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2017

Planlagt Fastgjort Låst Flyttet Genmab
4.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #133

    Poseida Therapuetics paper on CAR-T; apparantly they are collaborating with J&J’s Janss
    en to develop this... didn't know that... https://ash.confex.com/ash/2017/webprogram/Paper108439.html

    1 Reply Last reply
    0
    • G Offline
      G Offline
      gentogen
      wrote on sidst redigeret af
      #134

      After 3 years of median follow-up, single-agent DARA continues to demonstrate a favorable safety profile with no new safety signals. Deep and durable responses continue to be maintained in a subset of these heavily pretreated patients. With over one-third of patients remaining alive after 3 years of study entry, these findings highlight the activity of single-agent DARA

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #135

        Link Preview Image
        Webprogram Unavailable

        favicon

        (ash.confex.com)

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #136

          An accelerated infusion rate of daratumumab delivering 20% of the dose over 30 minutes and 80% over 60 minutes is feasible and well-tolerated in patients who have received 2 prior doses of daratumumab at standard infusion rates. Starting with the third dose of daratumumab therapy, the 90-minute infusion is now standard practice at our institution. https://ash.confex.com/ash/2017/webprogram/Paper102870.html

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #137

            Det er et par rigtig gode oplysning gentogen !

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #138

              tak gentogen. Lad os håbe det breder sig (og det gør det nok) indtil sc dara løser problemet endegyldigt.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #139

                90 minutes! hadn't heard about that yet; that will indeed solve a lot of practical problems for now!

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #140

                  ASH overview from JNJ:
                  https://www.jnj.com/media-center/press-releases/ash-2017-janssen-to-present-40-abstracts-including-8-oral-presentations-with-new-data-on-darzalex-daratumumab-imbruvica-ibrutinib-and-other-compounds-from-robust-portfolio?utm_source=Direct

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #141

                    shows the most important for them is sc, smoldering, Castor & Pollux i guess

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #142

                      Mens vi venter på Alcyone skal vi ikke glemme, at der faktisk er andre frontline-data på ASH. 2 abstracts om dara-CyBorD, hvoraf det ene (det lille rent irske) melder om lovende effektivitets-data. Mig bekendt de første effektivitets-data vi hører om fra frontline. https://ash.confex.com/ash/2017/webprogram/Paper101050.html

                      1 Reply Last reply
                      0
                      • JonSnowJ Offline
                        JonSnowJ Offline
                        JonSnow
                        wrote on sidst redigeret af
                        #143

                        Kan regnskabet d. 8 være kursdrivende?

                        1 Reply Last reply
                        0
                        • T Offline
                          T Offline
                          Thomas
                          wrote on sidst redigeret af
                          #144

                          Historisk tror jeg det har været en dårlig forretning at være Genmab-ejer på dagen for regnskab. JonSnow, det vil være en overraskelse hvis regnskabet vil sætte fut under kursen

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bibob
                            wrote on sidst redigeret af
                            #145

                            God morgen 🙂

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #146

                              God morgen. 🙂

                              1 Reply Last reply
                              0
                              • H Offline
                                H Offline
                                henrik48
                                wrote on sidst redigeret af
                                #147

                                God morgen - hvad tilsiger TA for Genmab eller er dette mindre interessant for biotek ?

                                1 Reply Last reply
                                0
                                • Legolas23L Offline
                                  Legolas23L Offline
                                  Legolas23
                                  wrote on sidst redigeret af
                                  #148

                                  Der er en tråd på den konkurrende kanal EI, hvor der bliver talt om TA i Genmab

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #149

                                    Synes salgspresset virker aftagende og der er kobere i 1260 - 1300 omraadet

                                    1 Reply Last reply
                                    0
                                    • O Offline
                                      O Offline
                                      OHW
                                      wrote on sidst redigeret af
                                      #150

                                      Biotek styres af FA nyheder som ofte driver kursen meget mere op og ned end vi normalt ser i "normale" virksomheder. Men derfor er det da meget underholdende at se lidt på kort TA, som ofte holder i nyhedsfattige perioder. Nu skal vi nok gave testet niveau 1220-1240 som efterfølges af et "psykologisk" ikke TA baseret 1200 og derefter mere vigtigt 1180. Husk at TA nok har regler men der er vide fortolkninger og jeg er sikker på, at andre ser andre niveauer der er vigtige end jeg gør.

                                      1 Reply Last reply
                                      0
                                      • O Offline
                                        O Offline
                                        OHW
                                        wrote on sidst redigeret af
                                        #151

                                        ..jeg tror 1220-1240 niveau vil holde..

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #152

                                          Det får du nok ret i. 970 holdt jo også:-)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger